Bulk Ozagrel Sodium CAS 189224-26-8 for Pharmaceutical Supply

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: ST-Ozagrel Sodium
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Other Name: Ozagrel Sodium Powder
• Shelf Life: 2 Years
• Code: 3009125475
• Product Name: Ozagrel Sodium
• Others Name: Ozagrel Sodium Price
• MOQ: 10g
• Storage: Cool Dry Place
• Formula Weight: 250.23
• Test Methods: HPLC
• Molecular Formula: C13h11n2nao2
• Place of Origin: Shanxi
• Function: Neuroprotection
• Sample: Available
• Environmental Protection: Yes
• Heath: Yes
• Transport Package: Aluminium Bag Outside and Double Plastic Bag Insid
• Specification: 99%
• Trademark: SENTIAN
• Origin: China
• Production Capacity: 50000

Product Description

Description

 Ozagrel sodium is a sodium salt form of antiplatelet agglutinant Ozagrel. It is a thromboxane (TXA) synthase inhibitor. It can selectively inhibit thromboxane synthase and TXA synthesis, so as to inhibit the production of TXA2 and promote the production of prostacyclin (PGI2). It has the effects of anti platelet aggregation and relieving vasospasm. It can inhibit cerebral embolism and cerebral vasospasm. Ozagrel sodium is a sodium salt form of antiplatelet agglutinant Ozagrel. It is a thromboxane (TXA) synthase inhibitor. It can selectively inhibit thromboxane synthase and TXA synthesis, so as to inhibit the production of TXA2 and promote the production of prostacyclin (PGI2). It has the effects of anti platelet aggregation and relieving vasospasm. It can inhibit cerebral embolism and cerebral vasospasm.
 

Product Name	Ozagrel Sodium
Appearance	White Powder
CAS NO.	189224-26-8
Molecular Formula	C13H11N2NaO2
Storage	Keep in a cool, dry, dark location

 

 

Application & Funtion

 

 

1. Cerebrovascular Diseases: Administered to patients with acute ischemic stroke, including cerebral infarction, to improve cerebral blood flow and reduce the risk of further neurological damage.
2. Prevention of Thrombosis: Used to prevent the formation of blood clots in patients with high risk of thrombosis, such as those with cardiovascular disease or undergoing surgical procedures.
3. Adjuvant Therapy: May be used as an adjuvant therapy in combination with other medications to enhance the treatment outcome in cerebrovascular and cardiovascular conditions.

 

• Inhibition of Platelet Aggregation: By inhibiting the synthesis of thromboxane A2, Ozagrel Sodium blocks the platelet aggregation pathway, thereby reducing the risk of thrombus formation.
• Vasodilation: It has vasodilatory effects, which help to reduce vascular spasms and improve blood flow to the affected areas.
• Neuroprotection: By improving cerebral blood flow and energy metabolism, Ozagrel Sodium may exert neuroprotective effects, aiding in the recovery of neurological function in patients with cerebrovascular disorders.

 

COA

 

Items	Requirements	Results
Physical & Chemical
Appearance	White powder	Conform
Odor	Characteristic	Characteristic
Particle Size	98% pass 80mesh	Complies
Loss on Drying	≤5.0%	3.65%
Ash	≤5.0%	1.96%
Solvent Residue	Meet USP standard	Complies
Pesticide Residue	Meet USP standard	Complies
Heavy Metal
Lead (Pb)	≤2.0ppm	Conform
(As)	≤1.0ppm	Conform
(Cd)	≤1.0ppm	Conform
(Hg)	≤0.1ppm	Conform
Microorganism
Total Plate Count	≤1000cfu/g	Conform
Yeasts and Molds	≤100cfu/g	Conform
Saimonella	Negative/25g	Conform
E.coli	Negative	Conform
Assay	98%	98.5%

 

Company